These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1568412)

  • 1. Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture.
    Mottolese M; Cianciulli A; Venturo I; Perrone Donnorso R; Salzano M; Benevolo M; Bigotti G; Natali PG
    Diagn Cytopathol; 1992; 8(2):153-60. PubMed ID: 1568412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin.
    Mottolese M; Venturo I; Donnorso RP; Curcio CG; Rinaldi M; Natali PG
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1277-84. PubMed ID: 3053205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
    Ghosh AK; Mason DY; Spriggs AI
    J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytological analysis of the Tn associated antigen 83D4 in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein.
    Beuzelin-Yvraut M; Bourguignat A; Phillips E; Roseto A; Osinaga E
    J Clin Pathol; 1995 May; 48(5):433-7. PubMed ID: 7629290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
    Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
    Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a soluble antigen defined by monoclonal antibody 83D4 in serous effusions associated with breast carcinoma.
    Osinaga E; Pancino G; Beuzelin M; Babino A; Rodriguez D; Robello C; Tiscornia A; Phillips E; Bourguignat A; Roseto A
    Cancer; 1992 Apr; 69(7):1745-9. PubMed ID: 1551059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the expression of CEA and a myelomonocytic antigen (CD15) in serous effusions using two monoclonal antibodies NEO 723 and Leu M1].
    Daste G; Berthier F; Mauduyt MA; Soleilhavoup JP
    Arch Anat Cytol Pathol; 1992; 40(4):183-9. PubMed ID: 1294046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AUA1: new immunocytochemical marker for detecting epithelial cells in body cavity fluids.
    Kocjan G; Sweeney E; Miller KD; Bobrow L
    J Clin Pathol; 1992 Apr; 45(4):358-9. PubMed ID: 1577978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of second malignancies on effusions and fine-needle aspirates using a panel of monoclonal antibodies.
    Mottolese M; Venturo I; Rinaldi M; Lopez M; Bigotti G; Benevolo M; Natali PG
    Br J Cancer; 1997; 75(4):572-8. PubMed ID: 9052413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature.
    Davidson B
    Anal Cell Pathol; 2001; 23(3-4):107-28. PubMed ID: 12082292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies.
    Shaw P; Buckman R; Law J; Baumal R; Marks A
    Tumour Biol; 1988; 9(2-3):101-9. PubMed ID: 3041546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.
    Ghosh AK; Spriggs AI; Taylor-Papadimitriou J; Mason DY
    J Clin Pathol; 1983 Oct; 36(10):1154-64. PubMed ID: 6194183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of monoclonal antibody B72.3 as a marker of metastatic carcinoma cells in neoplastic effusions.
    Betta PG; Pavesi M; Pastormerlo M; Tallarida F; Bellingeri D; Bocca R
    Pathologica; 1991; 83(1083):99-104. PubMed ID: 1866206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of monoclonal antibody for assessment of estrogen and progesterone receptors in malignant effusions.
    Masood S
    Diagn Cytopathol; 1992; 8(2):161-6. PubMed ID: 1568413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnostic value of B72.3, Ber-EP4 and calretinin in serous effusions].
    Li XJ; Pan QJ; Shen GH; Liu XY; Sun YT
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):438-41. PubMed ID: 16188134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the primary site of metastatic adenocarcinoma in serous effusions. Value of an immunocytochemical panel added to the clinical arsenal.
    Longatto Filho A; Alves VA; Kanamura CT; Nonogaki S; Bortolan J; Lombardo V; Bisi H
    Acta Cytol; 2002; 46(4):651-8. PubMed ID: 12146025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.
    Woods JC; Spriggs AI; Harris H; McGee JO
    Lancet; 1982 Sep; 2(8297):512-4. PubMed ID: 6125677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric identification of cancer cells in effusions with Ca1 monoclonal antibody.
    Czerniak B; Papenhausen PR; Herz F; Koss LG
    Cancer; 1985 Jun; 55(12):2783-8. PubMed ID: 3888371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.